CorMedix, Inc. (CRMD)
8.44
+0.16
(+1.93%)
USD |
NASDAQ |
Aug 25, 11:48
CorMedix EPS Diluted (Quarterly) : 0.281 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.281 |
| March 31, 2026 | 0.4151 |
| December 31, 2025 | 0.1493 |
| September 30, 2025 | 1.259 |
| June 30, 2025 | 0.2757 |
| March 31, 2025 | 0.2993 |
| December 31, 2024 | 0.2189 |
| September 30, 2024 | -0.0472 |
| June 30, 2024 | -0.2456 |
| March 31, 2024 | -0.2516 |
| December 31, 2023 | -0.2571 |
| September 30, 2023 | -0.1723 |
| June 30, 2023 | -0.2485 |
| March 31, 2023 | -0.2397 |
| December 31, 2022 | -0.1961 |
| September 30, 2022 | -0.1664 |
| June 30, 2022 | -0.1913 |
| March 31, 2022 | -0.1839 |
| December 31, 2021 | -0.2044 |
| September 30, 2021 | -0.2248 |
| June 30, 2021 | -0.1216 |
| March 31, 2021 | -0.1987 |
| December 31, 2020 | -0.1879 |
| September 30, 2020 | -0.223 |
| June 30, 2020 | -0.1447 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2133 |
| December 31, 2019 | -0.2067 |
| September 30, 2019 | -0.2192 |
| June 30, 2019 | -0.0292 |
| March 31, 2019 | -0.224 |
| December 31, 2018 | 0.1029 |
| September 30, 2018 | -0.5436 |
| June 30, 2018 | -0.5195 |
| March 31, 2018 | -0.6758 |
| December 31, 2017 | -0.75 |
| September 30, 2017 | -0.85 |
| June 30, 2017 | -0.4894 |
| March 31, 2017 | -0.935 |
| December 31, 2016 | -0.80 |
| September 30, 2016 | -1.15 |
| June 30, 2016 | -0.65 |
| March 31, 2016 | -0.55 |
| December 31, 2015 | -0.6168 |
| September 30, 2015 | -0.70 |
| June 30, 2015 | -0.65 |
| March 31, 2015 | -1.15 |
| December 31, 2014 | -0.4932 |
| September 30, 2014 | -1.15 |
| June 30, 2014 | -0.25 |
| March 31, 2014 | -4.35 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Innoviva, Inc. | -1.136 |
| Zevra Therapeutics, Inc. | 0.1368 |
| Filana Therapeutics, Inc. | -0.1781 |
| Eloxx Pharmaceuticals, Inc. | -0.6631 |
| Cannabis Global, Inc. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 25.99M |
| Revenue (Quarterly) | 101.93M |
| Total Expenses (Quarterly) | 75.94M |
| Enterprise Value | 530.88M |
| Gross Profit Margin (Quarterly) | 75.66% |
| Profit Margin (Quarterly) | 25.50% |
| Earnings Yield | 24.94% |
| Operating Earnings Yield | 28.14% |
| Normalized Earnings Yield | 26.09 |